SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Wells Fargo Maintains Boston Scientific at Equal-Weight, Cuts Target to $45

Wells Fargo lowered its price target from $48 to $45 while maintaining its Equal-Weight rating.

BSX

Story updates

02:12:52 PM UTC
SquawkNews
Boston Scientific Is Maintained at Equal-Weight by Wells Fargo

Related stories